Maastricht University
Maastricht, Limburg, 6200 MD, Netherlands
NCT Number: NCT03666013
The aim of this study is to characterize the relation between skeletal muscle mitochondrial metabolism and muscle health in elderly, physically compromised humans. To study this relation, a cross-sectional study will be performed in well-defined, distinct subject groups. Thus, to obtain insight in the relation between mitochondrial health and muscle function, not only subjects that differ in mitochondrial function (based on physical activity) will be compared but also subjects with high- versus low muscle function will be selected.
Looking for future studies?
Notify Me65 year–80 year
All sexes
Observational
Maastricht, Limburg, 6200 MD, Netherlands
Aging is associated with a decline of mitochondrial and skeletal muscle volume, -quality and -function. If a causal link exists between the loss of mitochondrial function and muscle health is unknown, however, both appear with advancing age and are associated with the loss of functional capacity, which increases comorbidities and annual healthcare costs. The aim is to test the hypothesis that a compromised muscle function in sedentary elderly is related to an impaired mitochondrial health. A detailed characterization of mitochondrial metabolism and muscle function is performed in well-defined, (physically compromised) elderly humans, in a cross-sectional design. To obtain insight in the relation between mitochondrial health and muscle function, not only elderly subjects that differ in mitochondrial function (based on physical activity) will be compared but also elderly subjects with high versus low muscle physical function will be selected. Healthy, young (20-30 years,) individuals with normal physical activity levels will be included as absolute controls.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Aneurysm clips Implanted neural stimulator Implanted cardiac pacemaker of defibrillator Cochlear implant Iron- containing corpora aliena in the eye or brain Artificial (heart) valves which is contraindicated for MRS Claustrophobia
Time frame: Day 4
Ex vivo mitochondrial capacity, ADP-stimulated respiration expressed by O2flux in pmol/mg wet weight/second
Time frame: Day 1
Measured by 1-step hyperinsulinemic euglycemic. Insulin-stimulated glucose disposal, expressed as the rate of disappearance of the glucose (Rd glucose in μmol*kg-1*bw*min-1
Time frame: Day 2
Measured by a standardized 6-minute walk test. Physical functionality expressed in the distance (in meters) the subject is able to walk over a total of six minutes
Time frame: Day 2
Maximal oxygen uptake measured by maximal cycling test (ml*kg-1*min-1)
Time frame: Day 3
Measured by BodPod and expressed by percentages of fat mass (%)
Time frame: Day 3
Characterized by using the CAREN-system locomotion assessment and expressed by amount of steps necessary to regain normal walking pattern
Time frame: Day 3
Extensor and flexor muscles of the knee joint measured by dynamometer (Biodex) expressed in peak torque 70° extension and flexion knee (Nm/kg)
Time frame: Day 4
indirect calorimetry during 45 minutes in resting state (in KJ/min) and 1-hour exercise bout at 50% of maximal power output (in KJ/min)
Time frame: Day 5
In vivo skeletal muscle PCr-recovery expressed by PCr halftime (s)
Time frame: Day 5
In vivo skeletal muscle acetylcarnitine concentrations in rest measured by H-MRS and expressed by mmol/kgww
Time frame: Day 5
Muscle volume measured by MRI
Maastricht University
Other
Mitochondrial Health and Muscle Function in Elderly
Acronym: ELMIH
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05956964
Mental Disorders, Muscle Weakness
Lexington, Kentucky, United States
View Trial DetailsNCT06216015
Chronic Disease, Chronic Kidney Failure
View Trial DetailsNCT07555782
Anterior Cruciate Ligament Injuries, Anterior Cruciate Ligament Rupture
Ataşehir, Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07590557
Burn Injury, Burns
Al Kharj, Saudi Arabia
View Trial Details